Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Enterolactone in breast cyst fluid: correlation with EGF and breast cancer risk.

Boccardo F, Lunardi GL, Petti AR, Rubagotti A.

Breast Cancer Res Treat. 2003 May;79(1):17-23.

PMID:
12779078
2.

Serum enterolactone levels and the risk of breast cancer in women with palpable cysts.

Boccardo F, Lunardi G, Guglielmini P, Parodi M, Murialdo R, Schettini G, Rubagotti A.

Eur J Cancer. 2004 Jan;40(1):84-9.

PMID:
14687793
3.

Epidermal growth factor in breast cyst fluid: relationship with intracystic cation and androgen conjugate content.

Boccardo F, Valenti G, Zanardi S, Cerruti G, Fassio T, Bruzzi P, De Franchis V, Barreca A, Del Monte P, Minuto F.

Cancer Res. 1988 Oct 15;48(20):5860-3.

4.

Epidermal growth factor content of breast cyst fluids from women with breast cancer or proliferative disease of the breast.

Torrisi R, Zanardi S, Pensa F, Valenti G, De Franchis V, Nicolo G, Barreca A, Minuto F, Boccardo F.

Breast Cancer Res Treat. 1995 Mar;33(3):219-24.

PMID:
7749149
5.

Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland.

Pietinen P, Stumpf K, Männistö S, Kataja V, Uusitupa M, Adlercreutz H.

Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):339-44.

6.

Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study.

Guglielmini P, Rubagotti A, Boccardo F.

Breast Cancer Res Treat. 2012 Apr;132(2):661-8. doi: 10.1007/s10549-011-1881-8. Epub 2011 Nov 18.

PMID:
22094938
7.

Intracystic epidermal growth factor level is predictive of breast-cancer risk in women with gross cystic disease of the breast.

Boccardo F, Marenghi C, Ghione G, Pepe A, Parodi S, Rubagotti A.

Int J Cancer. 2001 Jul 20;95(4):260-5. Erratum in: Int J Cancer 2001 Nov 20;95(6):398.

8.

Epidermal growth factor levels in human breast cyst fluid.

Battaglia F, Rossi S, Scambia G, Lanzone A, Benedetti-Panici P, Ferrandina G, Lombardi CP, Bellantone R, Crucitti F, Mancuso S.

Anticancer Res. 1989 Nov-Dec;9(6):1661-3.

PMID:
2627118
9.

Epidermal growth factor and oestradiol in human breast cyst fluid.

Lai LC, Dunkley SA, Reed MJ, Ghilchik MW, Shaikh NA, James VH.

Eur J Cancer. 1990 Apr;26(4):481-4.

PMID:
2141515
10.

Relationship between epidermal growth factor and dehydroepiandrosterone and its sulphate in breast cyst fluid.

Lai LC, Ghilchik MW, Shaikh NA, Reed MJ, James VH.

Br J Cancer. 1989 Sep;60(3):320-3.

11.

Cathepsin D and epidermal growth factor in human breast cyst fluid.

Scambia G, Benedetti Panici P, Ferrandina G, Battaglia F, Rossi S, Bellantone R, Crucitti F, Mancuso S.

Br J Cancer. 1991 Nov;64(5):965-7.

12.

Prediagnostic plasma enterolactone levels and mortality among women with breast cancer.

Olsen A, Christensen J, Knudsen KE, Johnsen NF, Overvad K, Tjønneland A.

Breast Cancer Res Treat. 2011 Aug;128(3):883-9. doi: 10.1007/s10549-011-1397-2. Epub 2011 Feb 22.

PMID:
21340481
13.

Plasma enterolactone and breast cancer incidence by estrogen receptor status.

Olsen A, Knudsen KE, Thomsen BL, Loft S, Stripp C, Overvad K, Møller S, Tjønneland A.

Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2084-9.

14.

Plasma enterolactone and genistein and the risk of premenopausal breast cancer.

Piller R, Chang-Claude J, Linseisen J.

Eur J Cancer Prev. 2006 Jun;15(3):225-32.

PMID:
16679865
15.

An incident case-referent study on plasma enterolactone and breast cancer risk.

Hultén K, Winkvist A, Lenner P, Johansson R, Adlercreutz H, Hallmans G.

Eur J Nutr. 2002 Aug;41(4):168-76.

PMID:
12242585
16.

Tumour necrosis factor-alpha and interleukin-1 and -6 in fibrocystic breast disease.

Herruzo A, Castilla JA, Ramírez A, Marcos C, Menjón S.

Breast Cancer Res Treat. 1999 Mar;54(2):159-64.

PMID:
10424406
17.

Serum enterolactone and prognosis of postmenopausal breast cancer.

Buck K, Vrieling A, Zaineddin AK, Becker S, Hüsing A, Kaaks R, Linseisen J, Flesch-Janys D, Chang-Claude J.

J Clin Oncol. 2011 Oct 1;29(28):3730-8. doi: 10.1200/JCO.2011.34.6478. Epub 2011 Sep 6.

PMID:
21900115
18.

Oestradiol and epidermal growth factor in breast cyst fluid.

Lai LC, Dunkley SA, Reed MJ, Ghilchik MW, James VH.

Anticancer Res. 1989 Nov-Dec;9(6):1853-6.

PMID:
2627131
19.

Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study.

Sonestedt E, Borgquist S, Ericson U, Gullberg B, Olsson H, Adlercreutz H, Landberg G, Wirfält E.

Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3241-51. doi: 10.1158/1055-9965.EPI-08-0393.

20.

The protective association of high plasma enterolactone with breast cancer is reasonably robust in women with polymorphisms in the estrogen receptor alpha and beta genes.

Sonestedt E, Ivarsson MI, Harlid S, Ericson U, Gullberg B, Carlson J, Olsson H, Adlercreutz H, Wirfält E.

J Nutr. 2009 May;139(5):993-1001. doi: 10.3945/jn.108.101691. Epub 2009 Mar 25.

Supplemental Content

Support Center